Company news
Vincent Mileto named to NJBIZ’s 2025 People to Watch in Health Care
NJBIZ recognizes Orcosa’s Co-Founder and Chief Operating Officer for his work advancing a new approach to taking medicine.
Orcosa’s Co-Founder and Chief Operating Officer Vincent T. Mileto has been named to NJBIZ’s 2025 People to Watch in Health Care. Published on July 14, the list recognizes professionals whose contributions are helping shape health care across New Jersey.
NJBIZ highlighted Mileto’s work on Orcosa’s RITe™ Platform and his pharmaceutical manufacturing experience. The publication described his role overseeing Orcosa’s platform development, manufacturing, engineering, laboratory and quality assurance functions.
For Orcosa, the recognition reflects a shared ambition: developing medicines that account for how people actually take them. RITe™ is the company’s proprietary tablet technology, designed to support that approach across a pipeline of investigational medicines. Its development brings together formulation expertise, manufacturing capabilities and a focus on the patient experience.
In acknowledging the honor, Mileto credited the Orcosa team and reaffirmed its focus on translating the platform into products designed around patients’ needs. His inclusion on the list brings broader attention to the work behind Orcosa’s technology and the people advancing it.
Read the original NJBIZ feature for Mileto’s profile and the complete 2025 list.
Back to all news